You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Bristol Myers Squibb’s Camzyos gets NICE recommendation

Bristol Myers Squibb (BMS) has announced that the National Institute for Health and Care Excellence (NICE) has published final guidance recommending its Camzyos drug for use across the NHS.